Prognostic value of CD163+ macrophages in solid tumor malignancies: A scoping review
Open Access
- 6 January 2025
- journal article
- review article
- Published by Elsevier in Immunology Letters
- Vol. 272, 106970
Abstract
No abstract availableKeywords
This publication has 174 references indexed in Scilit:
- Cellular dynamics in tumour microenvironment along with lung cancer progression underscore spatial and evolutionary heterogeneity of neutrophilClinical and Translational Medicine, 2023
- The prognostic value of a 4-factor neoimmunologic score system in non-small cell lung cancerJournal of Leukocyte Biology, 2022
- Tumor‐associated macrophages and risk of recurrence in stage III colorectal cancerThe Journal of Pathology: Clinical Research, 2022
- Infiltration of NK and plasma cells is associated with a distinct immune subset in non‐small cell lung cancerThe Journal of Pathology, 2021
- Immunological impact of chemotherapy on the tumor microenvironment in gastric cancerJournal of Surgical Oncology, 2021
- CD163+ tumor‐associated macrophage accumulation in breast cancer patients reflects both local differentiation signals and systemic skewing of monocytesClinical & Translational Immunology, 2020
- Expression of scavenger receptor MARCO defines a targetable tumor‐associated macrophage subset in non‐small cell lung cancerInternational Journal of Cancer, 2018
- Prognostic significance of the infiltration of CD163+ macrophages combined with CD66b+ neutrophils in gastric cancerCancer Medicine, 2018
- Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival timeInternational Journal of Cancer, 2009
- Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survivalInternational Journal of Cancer, 2008